Nanopath

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. Nanopath is based in Cambridge, MA and was founded in 2019. It was valued at $32 million at its early-stage round in Aug 2022, the last priced event on record. It has raised $16.4 million across 2 recorded rounds; the latest was a $5.3 million debt round in Jan 2025.

PMV mark · valuation
$32.0M
Oct 2026
Priced at
its early-stage round
Aug 2022
Total raised
$16.4M
Last round
Debt
Jan 2025
What is Nanopath worth?
$32.0MPrivateMarketView mark · Oct 2026

Valued at $32.0M at its early-stage round, Aug 2022. Nothing has traded since.

Free account
More of Nanopath with a free account
  • ·The complete investor list: 17 names
  • ·Watch Nanopath: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Nanopath funding history

2 rounds
DateRoundRaisedPost-money
Jan 2025Debt$5.3M▮
Jun 2022Early Stage VC$10.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Nanopath valuation

Nanopath was valued at $32 million at its early-stage round in Aug 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Nanopath raised?

Nanopath has raised $16.4 million across 2 recorded rounds since 2022. The largest was a $5.3 million debt round in Jan 2025.

Nanopath has filed 2 Form Ds with the SEC since 2022, most recently in Feb 2025 ($5.3 million sold to 5 investors).

How Nanopath's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Nanopath, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Nanopath

What is Nanopath worth?
Nanopath is valued at $32.0M as of Oct 2026. Valued at $32.0M at its early-stage round, Aug 2022. Nothing has traded since.
How much has Nanopath raised?
Nanopath has raised $16.4M in total funding across 2 recorded rounds.
When did Nanopath last raise?
Nanopath last raised in Jan 2025 (Debt), raising $5.3M.